Exploring immune evasion of SARS-CoV-2 variants using a pseudotyped systemResearch Article Published on 2024-04-182024-09-05 Journal: Heliyon [Category] update2024, [키워드] ACE2-mCherry-293T Immune escape Neutralization assay pseudovirus SARS-CoV-2 [DOI] 10.1016/j.heliyon.2024.e29939 PMC 바로가기 [Article Type] Research Article
Development of a SARS‐CoV‐2 neutralization assay based on a pseudotyped virus using a HIV systemOriginal Article Published on 2024-03-222024-09-05 Journal: MedComm [Category] update2024, [키워드] fluorescent pseudovirus HIV system Neutralization assay SARS‐CoV‐2 [DOI] 10.1002/mco2.517 PMC 바로가기 [Article Type] Original Article
Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panelResearch Article Published on 2024-02-282024-09-05 Journal: Access Microbiology [Category] update2024, [키워드] antibodies COVID-19 immunoassays Neutralization assay SARS-CoV-2 Serological tests [DOI] 10.1099/acmi.0.000463.v4 PMC 바로가기 [Article Type] Research Article
Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vectorarticle Published on 2023-09-282024-09-05 Journal: Emerging Microbes & Infections [Category] update2024, [키워드] High-throughput Neutralization assay pseudovirus SARS-CoV-2 VSV [DOI] 10.1080/22221751.2023.2261566 PMC 바로가기 [Article Type] article
Diagnostic TR-FRET assays for detection of antibodies in patient samplesArticle Published on 2023-02-202024-09-05 Journal: Cell Reports Methods [Category] update2024, [키워드] CoraFluor Neutralization assay Serological testing TR-FRET assays vaccine efficacy studies [DOI] 10.1016/j.crmeth.2023.100421 PMC 바로가기 [Article Type] Article
Biomimetic nanoplasmonic sensor for rapid evaluation of neutralizing SARS-CoV-2 monoclonal antibodies as antiviral therapyArticle Published on 2023-02-082024-09-05 Journal: Biosensors & bioelectronics [Category] update2024, [키워드] COVID-19 Immunotherapy Label-free analysis Neutralization assay Supported lipid bilayer surface plasmon resonance [DOI] 10.1016/j.bios.2023.115137 PMC 바로가기 [Article Type] Article
Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variantsArticle Published on 2022-12-012022-11-15 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] addition adenoviral vector Adenovirus adenovirus type 5 vector vaccine Anti-RBD IgG booster COVID-19 COVID-19 vaccine D614G demonstrated dose effective Efficacy IgA immunization Inactivated vaccine Inactivated Vaccines Inhaled lack mucosal Neutralization assay Neutralizing neutralizing antibody omicron Omicron variant BA.5 pandemic plasma Protective RBD SARS-CoV-2 SARS-CoV-2 pseudovirus SARS-CoV-2 vaccines SARS-CoV-2 variant subunit titre Vaccination strategies Vaccination strategy Vaccine variant virus widespread [DOI] 10.1080/22221751.2022.2132881 PMC 바로가기
The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockade장기간의 백신 유발 항SARS-CoV-2 면역 반응은 TNFα 차단으로 인해 양과 질이 저하됩니다.Article Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 백일해, 변종, 진단, 파상풍, [키워드] Activation acute respiratory syndrome alteration analysed anti-SARS-CoV-2 anti-SARS-CoV-2 IgG anti-TNF-α appear Autoimmune Autoimmune diseases blockade bystander Cell changes in chronic inflammatory disease Cohort comparable Control coronavirus COVID-19 Decline drugs Effect Efficacy ELISA flow cytometry groups healthy humoral immune response IgG immune cell populations immune response immunoblot investigated less Live virus Necrosis Neutralization assay neutralize neutralizing antibody neutralizing capacity Older omicron Patient patients plasma Plasma cell recipient reduced response SARS-CoV-2 second vaccination significantly T cell subset titre TNF-α TNFα tumor necrosis factor inhibitors tumor necrosis factor-α vaccination Vaccine variants of concern virus VoC was increased while [DOI] 10.1002/jmv.28063 PMC 바로가기
Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domainSARS-CoV-2 S2 도메인에 대한 항체의 결합 및 중화 능력Article Published on 2022-11-302022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibodies antibody B.1.1.7 B.1.351 B.1.617.2 B.1.621 binding binding activity carried conserved convalescent patient coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 determined by domain ELISA enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay evaluated Evidence Immune escape immune protection mAb mAbs MERS MERS-CoV Middle East Middle East respiratory syndrome Middle East respiratory syndrome Coronavirus molecular monoclonal antibodies monoclonal antibody N Terminal N terminal domain NAbs Neutralization assay neutralization assay. Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody NTD P.1 Protein pseudo-virus RBD Receptor binding domain reported Research respiratory Result S protein S proteins S2 protein S2 subunit SARS-CoV SARS-CoV-2 SARS-CoV-2 RBD SARS-CoV-2 S SARS-CoV-2 S2 SARS-CoV-2 WT Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus significantly specific antibodies subunit target targets terminal Vaccine design variant variants wild-type [DOI] 10.1080/21645515.2022.2055373 PMC 바로가기 [Article Type] Article
Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodiesArticle Published on 2022-11-082022-11-15 Journal: Scientific Reports [Category] SARS, 치료기술, [키워드] acute respiratory syndrome administration affecting Analysis anti-RBD IgG antibody anti-SARS-CoV-2 AUC automated binding antibody booster clinical settings Cohort collected Control coronavirus correlation COVID-19 cutoff value demonstrated Effectiveness Genscript gold standard Immunity immunoassay in both groups infected patient Mindray NAb neutralization Neutralization assay neutralization test neutralizing antibody population level protective immunity provide pseudovirus R 2 Rapid receiver operating characteristic Research ROC ROC Curve Sample SARS-CoV-2 SARS-CoV-2 infected patient second dose sensitivity shown significantly specificity subjects sVNT sVNT assay symptoms onset tested threshold vaccinated individual Vaccine virus neutralization test was performed [DOI] 10.1038/s41598-022-21317-x PMC 바로가기